Automated Insulin Delivery Improves Glycemic Control in Diverse Adults with Type 2 Diabetes, Study Finds Medha Baranwal7 March 2025 9:15 AM ISTUSA: A recent nonrandomized clinical trial has shown promising results for automated insulin delivery (AID) systems in managing type 2 diabetes (T2D)....
New insights into insulin action: Dynamic signaling network offers therapeutic approaches for type 2 diabetes Dr. Kamal Kant Kohli6 March 2025 8:00 AM ISTResearchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Dusseldorf (HHU) have studied the temporal pattern of insulin...
Frequent Daytime Napping Linked to Higher Cardiovascular Risk in Diabetes, finds Study Dr Riya Dave5 March 2025 9:45 AM ISTA new study identified daytime napping at frequent intervals to be linked to higher risks of major adverse cardiovascular events (MACE) and death in...
Efficacy of Diabetes Treatments Varies by Age and Sex: SGLT2 Inhibitors More Effective in Older Adults, Study Reveals Medha Baranwal4 March 2025 9:00 AM ISTScotland: A recent network meta-analysis has revealed significant age and sex differences in the efficacy of treatments for type 2 diabetes, offering...
GLP-1 drug shows little benefit for people with Parkinson's disease: Study Dr. Kamal Kant Kohli2 March 2025 9:30 PM ISTThe GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL...
Elevated PAI-1 Levels May Predict Type 2 Diabetes Before Blood Sugar Rises: Study Suggests Medha Baranwal1 March 2025 8:45 AM ISTSweden: New research suggests that elevated levels of plasminogen activator inhibitor-1 (PAI-1) in individuals without diabetes may serve as an early...
Medical Bulletin 27/ February/ 2025 Dr. Bhumika Maikhuri27 Feb 2025 3:00 PM ISTHere are the top medical news for the day:Predicting Future Health: Organ Age Biomarkers Foretell Disease Risk Decades EarlyOur organs age at...
GLP-1 diabetes drugs not linked to heightened suicidality risk: Study Dr. Kamal Kant Kohli27 Feb 2025 9:00 AM ISTUse of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with two other groups of...
UK Innovation Revolutionizes Global Type 2 Diabetes Treatment: Study Shows Dr. Bhumika Maikhuri27 Feb 2025 8:30 AM ISTMillions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research...
GLP-1RAs may offer modest antidepressant effects compared to DPP4is but not SGLT-2is: Study Dr. Kamal Kant Kohli25 Feb 2025 10:45 PM ISTA target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with glucagon-like peptide-1...
Elevated LDL-C Tied to Coronary Artery Calcification in Asymptomatic Type 2 Diabetes Patients, Study Finds Medha Baranwal22 Feb 2025 9:00 AM ISTChina: A recent longitudinal study has highlighted the predictive role of low-density lipoprotein cholesterol (LDL-C) in coronary artery calcification...
Sotagliflozin significantly lowers Heart Attack and Stroke Risk, reports Lancet study Dr. Kamal Kant Kohli20 Feb 2025 9:00 AM ISTSotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular risk factors, has been...
